Montmorillonite nanoclay as a multifaceted drug-delivery carrier: A review

Journal of Drug Delivery Science and Technology

Volumn 39, Issue , 2017, Pages 200-209

  Jayrajsinh, Sarvaiya ^a   Shankar, Gauri ^a   Agrawal, Yadvendra K ^a   Bakre, Lateef ^b  

^a GUJARAT FORENSIC SCIENCES UNIVERSITY   (India)

^b OLABISI ONABANJO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; CATION; EXCIPIENT; IONIC SURFACTANT; MONTMORILLONITE; NONIONIC SURFACTANT;

DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; MOLECULAR INTERACTION; REVIEW; SAFETY; SUSTAINED DRUG RELEASE;

EID: 85016975554     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2017.03.023     Document Type: Review

References (117)

1. [1] Nagelschmidt, G., On the lattice shrinkage and structure of montmorillonite. Z Krist-Cryst Mater 93 (1936), 481–487.
2. [2] Tan, P., Yuan, B.F., Liu, D., He, H., Methoxy-modified kaolinite as a novel carrier for high capacity loading and controlled-release of the herbicide amitrole. Sci. Rep., 5, 2015, 8870.
3. [3] Mura, P., Maestrelli, F., Aguzzi, C., Viseras, C., Hybrid systems based on “drug–in cyclodextrin–in nanoclays” for improving oxaprozin dissolution properties. Int. J. Pharm. 509 (2016), 8–15.
4. [4] Elmore, S.E., Mitchell, N., Mays, T., Brown, K., Marroquin-Cardona, A., Romoser, A., Phillips, T.D., Common African cooking processes do not affect the aflatoxin binding efficacy of refined calcium montmorillonite clay. Food control. 37 (2014), 27–32.
5. [5] Summa, V., Tateto, F., Clay minerals as adsorbents of aflatoxin M1 fromcontaminated milk and effects on milk quality. Appl. Clay Sci. 88 (2014), 92–99.
6. [6] Mkhabela, V., Ray, S.S., Biodegradation and bioresorption of poly (ɛ-caprolactone) nanocomposite scaffolds. Int. J. Biol. Macromolec. 79 (2015), 186–192.
7. [7] Babu, S., Augustine, A., Kalarikkal, N., Thomas, S., Nylon 6, 12/Cloisite 30B ElectrospunNanocomposites for dental applications. J. Sib. Fed. Univ. Biol., 9, 2016, 198.
8. [8] Hsu, S.H., Wang, M.C., Lin, J.J., Biocompatibility and antimicrobial evaluation of montmorillonite/chitosan nanocomposites. Appl. Clay Sci. 56 (2012), 53–62.
9. [9] Ray, S.S., Okamoto, M., Polymer/layered silicate nanocomposites: a review from preparation to processing. Prog. Polym. Sci. 28 (2013), 1539–1641.
10. [10] Yadollahi, M., Farhoudian, S., Namazi, H., One-pot synthesis of antibacterial chitosan/silver bio-nanocomposite hydrogel beads as drug delivery systems. Int. J. Biol. Macromol. 79 (2015), 37–43.
11. [11] Likhitha, M., Sailaja, R.R., Priyambika, V.S., Ravibabu, M.V., Microwave assisted synthesis of guar gum grafted sodium acrylate/cloisite superabsorbent nanocomposites: reaction parameters and swelling characteristics. Int. J. Biol. Macromolec 65 (2014), 500–508.
12. [12] Cho, S.W., Gällstedt, M., Johansson, E., Hedenqvist, M.S., Injection-molded nanocomposites and materials based on wheat gluten. Int. J. Biol. Macromol. 48 (2011), 146–152.
13. [13] Edelman, C.T., Favejee, J.C., On the Crystal Structure of Montmorillonite and halloysite.ZeitschriftfürKristallographie-crystalline Materials, vol. 102, 1940, 417–431.
14. [14] Segad, M., Jonsson, B., Åkesson, T., Cabane, B., Ca/Na montmorillonite: structure, forces and swelling properties. Langmuir 26 (2010), 5782–5790.
15. [15] Tombácz, E., Szekeres, M., Colloidal behavior of aqueous montmorillonite suspensions: the specific role of pH in the presence of indifferent electrolytes. Appl. Clay Sci. 27 (2004), 75–94.
16. [16] Sciascia, L., Turco Liveri, M.L., Merli, M., Kinetic and equilibrium studies for the adsorption of acid nucleic bases onto K10 montmorillonite. Appl. Clay Sci., 53(657), 2011.
17. [17] Calabrese, I., Cavallaro, G., Lazzara, G., Merli, M., Sciascia, L., Turco Liveri, M.L., Preparation and characterization of bio-organoclays using nonionic surfactant. Adsorption 22 (2016), 105–116.
18. [18] Sánchez-Martín, M.J., Dorado, M.C., Del Hoyo, C., Rodríguez-Cruz, M.S., Influence of clay mineral structure and surfactant nature on the adsorption capacity of surfactants by clays. J. Hazard. Mater. 150 (2008), 115–123.
19. [19] Bertolino, V., Cavallaro, G., Lazzara, G., Merli, M., Milioto, S., Parisi, F., Sciascia, L., Effect of the biopolymer charge and the nanoclay morphology on nanocomposite materials. Ind. Eng. Chem. Res. 55 (2016), 7373–7380.
20. [20] Cavallaro, G., Lazzara, G., Massaro, M., Milioto, S., Noto, R., Parisi, F., Riela, S., Biocompatible poly(N-isopropylacrylamide)-halloysite nanotubes for thermoresponsive curcumin release. J. Phys. Chem. C 119 (2015), 8944–8951.
21. [21] Massaro, M., Amorati, R., Cavallaro, G., Guernelli, S., Lazzara, G., Milioto, S., Noto, R., Poma, P., Riela, S., Direct chemical grafted curcumin on halloysite nanotubes as dualresponsive prodrug for pharmacological applications. Colloids Surf. B 140 (2016), 505–513.
22. [22] Riela, S., Massaro, M., Colletti, C.G., Bommarito, A., Giordano, C., Milioto, S., Noto, R., Poma, P., Lazzara, G., Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity. Int. J. Pharm. 475 (2014), 613–623.
23. [23] Massaro, M., Colletti, C.G., Noto, R., Riela, S., Poma, P., Guernelli, S., Parisi, F., Milioto, S., Lazzara, G., Pharmaceutical properties of supramolecular assembly of co-loaded cardanol/triazole-halloysite systems. Int. J. Pharm. 478 (2015), 476–485.
24. [24] Massaro, M., Riela, S., Baiamonte, C., Blanco, J.L.J., Giordano, C., Lo Meo, P., Milioto, S., Noto, R., Parisi, F., Pizzolanti, G., Lazzara, G., Dual drug-loaded halloysite hybrid-based glycocluster Sustain. release hydrophobic Mol. RSC Adv. 6 (2016), 87935–87944.
25. [25] Aristilde, L., Marichal, C., Miéhé-Brendlé, J., Lanson, B., Charlet, L., Interactions of oxytetracycline with a smectite clay: a spectroscopic study with molecular simulations. Environ. Sci. Technol. 44 (2010), 7839–7845.
26. [26] Porubcan, L.S., Serna, C.J., White, J.L., Hem, S.L., Mechanism of adsorption of clindamycin and tetracycline by montmorillonite. J. Pharm. Sci. 67 (1978), 1081–1087.
27. [27] Suresh, R., Borkar, S.N., Sawant, V.A., Shende, V.S., Dimble, S.K., Nanoclay drug delivery system. Int. J. Pharm. SciNanotechnol. 3 (2010), 901–905.
28. [28] Vasudevan, D., Arey, T.A., Dickstein, D.R., Newman, M.H., Zhang, T.Y., Kinnear, H.M., Bader, M.M., Nonlinearity of cationic aromatic amine sorption to aluminosilicates and soils: role of intermolecular cation− π interactions. Environ. Sci. Technol., 47, 2013, 14119.
29. [29] Patel, H.A., Somani, R.S., Bajaj, H.C., Jasra, R.V., Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment. Bull. Mater. Sci. 29 (2006), 133–145.
30. [30] Pavlukhina, S., Zhuk, I., Mentbayeva, A., Rautenberg, E., Chang, W., Yu, X., van de Belt- Gritter, B., Busscher, H.J., van der Mei, H.C., Sukhishvili, S.A., Small-molecule-hosting nanocomposite films with multiple bacteria-triggered responses. Pharm. Sci., 74, 2014, 292 NPG Asia Materials, 6, e121.
31. [31] Seki, Y., Yurdakoç, K., Adsorption of promethazine hydrochloride with KSF montmorillonite. Adsorption 12 (2006), 89–100.
32. [32] Zheng, J., Shan, J., Fan, Z., Yao, K., Preparation and properties of gelatin- chitosan/montmorillonite drug-loaded microspheres. J. Wuhan Univ. Technology-Mater. Sci. Ed. 26:4 (2011), 628–633.
33. [33] Tan, D., Yuan, P., Annabi-Bergaya, F., Liu, D., He, H., High-capacity loading of 5- fluorouracil on the methoxy-modified kaolinite. Appl. Clay Sci. 100 (2014), 60–65.
34. [34] Yan, H., Chen, X., Wu, T., Feng, Y., Wang, C., Li, J., Lin, Q., Mechanochemical modification of kaolin surfaces for immobilization and delivery of pesticides in alginate-chitosan composite beads. Polym. Bull. 71 (2014), 2923–2944.
35. [35] LeBaron, P.C., Wang, Z., Pinnavaia, T.J., Polymer-layered silicate nanocomposites: an overview. Appl. clay Sci. 15 (1999), 11–29.
36. [36] Ray, S.S., Okamoto, M., Polymer/layered silicate nanocomposites: a review from preparation to processing. Prog. Polym. Sci. 28 (2003), 1539–1641.
37. [37] Kan, T., Jiang, X., Zhou, L., Yang, M., Duan, M., Liu, P., Jiang, X., Removal of methyl orange from aqueous solutions using a bentonite modified with a new gemini surfactant. Appl. Clay Sci. 54 (2011), 184–187.
38. [38] Bongartz, R., Ag, D., Seleci, M., Walter, J.G., Yalcinkaya, E.E., Demirkol, D.O., Stahl, F., Timur, S., Scheper, T., Folic acid-modified clay: targeted surface design for cell culture applications. J. Mater. Chem. B 1 (2013), 522–528.
39. [39] Kooli, F., Liu, Y., Alshahateet, S.F., Messali, M., Bergaya, F., Reaction of acid activated montmorillonites with hexadecyltrimethylammonium bromide solution. Appl. Clay Sci. 4 (2009), 357–363.
40. [40] Zhang, Z.Z., Sparks, D.L., Scrivner, N.C., Sorption and desorption of quaternary amine cations on clays. Environ. Sci. Technol. 27 (1993), 1625–1631.
41. [41] Yu, W.H., Li, N., Tong, D.S., Zhou, C.H., Lin, C.X., Xu, C.Y., Adsorption of proteins and nucleic acids on clay minerals and their interactions: a review. Appl. Clay Sci. 80 (2013), 443–452.
42. [42] Maiti, P., Yamada, K., Okamoto, M., Ueda, K., Okamoto, K., New polylactide/layered silicate nanocomposites: role of organoclays. Chem. Mater. 14 (2002), 4654–4661.
43. [43] Singla, P., Mehta, R., Upadhyay, S.N., Clay modification by the use of organic cations. Green Sustain. Chem., 2, 2012, 21.
44. [44] Zawrah, M.F., Khattab, R.M., Saad, E.M., Gado, R.A., Effect of surfactant types and their concentration on the structural characteristics of nanoclay. Spectrochimica Acta Part A Mol. Biomol. Spectrosc. 122 (2014), 616–623.
45. [45] He, H., Ma, Y., Zhu, J., Yuan, P., Qing, Y., Organoclays prepared from montmorillonites with different cation exchange capacity and surfactant configuration. Appl. Clay Sci. 48 (2010), 67–72.
46. [46] He, H., Ma, L., Zhu, J., Frost, R.L., Theng, B.K., Bergaya, F., Synthesis of organoclays: a critical review and some unresolved issues. Appl. Clay Sci. 100 (2014), 22–28.
47. [47] Bate, B., Burns, S.E., Effect of total organic carbon content and structure on the Electrokinetic behavior of organoclay suspensions. J. colloid interface Sci. 343 (2010), 58–64.
48. [48] Chen, D., Chen, J., Luan, X., Ji, H., Xia, Z., Characterization of anion–cationic surfactants modified montmorillonite and its application for the removal of methyl orange. Chem. Eng. J. 171:3 (2011), 1150–1158.
49. [49] Zhang, Z., Liao, L., Xia, Z., Ultrasound-assisted preparation and characterization of anionic surfactant modified montmorillonites. Appl. Clay Sci. 50 (2010), 576–581.
50. [50] Chen, D., Deng, Y., Zhu, Q., Du, G., Zhou, F., Characterization of Cationic-nonionic surfactants modified montmorillonite and its application for the removal of nitrophenol. Sci. Adv. Mater. 5 (2013), 1041–1051.
51. [51] Wang, M.C., Lin, J.J., Tseng, H.J., Hsu, S.H., Characterization, antimicrobial activities, and biocompatibility of organically modified clays and their nanocomposites with polyurethane. ACS Appl. Mater. interfaces 4 (2011), 338–350.
52. [52] Cao, X., Wang, J., Liu, M., Chen, Y., Cao, Y., Yu, X., Chitosan collagen/organomontmorillonite scaffold for bone tissue engineering. Front. Mater. Sci. 9 (2015), 405–412.
53. [53] Beall, G.W., Goss, M., Self-assembly of organic molecules on montmorillonite. Appl. Clay Sci. 27 (2004), 179–186.
54. [54] Guégan, R., Self-assembly of a non-ionic surfactant onto a clay mineral for the preparation of hybrid layered materials. Soft Matter 9 (2013), 10913–10920 2013.
55. [55] Shen, Y.H., Prep. Organobent. using Nonion. surfactants.Chemosphere 44 (2001), 989–995.
56. [56] Deng, Y., Dixon, J.B., White, G.N., Bonding mechanisms and conformation of poly (ethylene oxide)-based surfactants in interlayer of smectite. Colloid Polym. Sci. 284 (2006), 347–356.
57. [57] Calabrese, I., Cavallaro, G., Lazzara, G., Merli, M., Sciascia, L., Turco Liveri, M.L., Preparation and characterization of bio-organoclays using nonionic surfactant. Adsorption 22 (2016), 105–116.
58. [58] Calabrese, I., Gelardi, G., Merli, M., Turco Liveri, M.L., Sciascia, L., Clay- biosurfactant materials as functional drug delivery systems: slowing down effect in the in vitro release of cinnamic acid. Appl. Clay Sci. 135 (2017), 567–574.
59. [59] Balme, S., Guégan, R., Janot, J.M., Jaber, M., Lepoitevin, M., Dejardin, P., Bourrat, X., Motelica Heino, M., Structure, orientation and stability of lysozyme confined in layered materials. Soft Matter 9 (2013), 3188–3196.
60. [60] Guégan, R., Confinement effects on water structure in membrane lyotropic phases. J. Colloid Interface Sci. 358 (2011), 485–490.
61. [61] Guégan, R., Giovanela, M., Warmont, F., Motelica-Heino, M., Nonionic organoclay: a ‘Swiss Army knife'for the adsorption of organic micro-pollutants?. J. colloid interface Sci. 437 (2015), 71–79.
62. [62] Zhuang, G., Zhang, Z., Guo, J., Liao, L., Zhao, J., A new ball milling method to produce organo-montmorillonite from anionic and nonionic surfactants. Appl. Clay Sci. 104 (2015), 18–26.
63. [63] Zhu, L., Chen, B., Shen, X., Sorption of phenol, p-nitrophenol, and aniline to dual- cation organobentonites from water. Environ. Sci. Technol. 34 (2000), 468–475.
64. [64] Jin, X., Hu, X., Wang, Q., Wang, K., Yao, Q., Tang, G., Chu, P.K., Multifunctional cationic polymer decorated and drug intercalated layered silicate (NLS) for early gastric cancer prevention. Biomaterials 35:10 (2014), 3298–3308 2014.
65. [65] Kevadiya, B.D., Rajkumar, S., Bajaj, H.C., Chettiar, S.S., Gosai, K., Brahmbhatt, H., Bhatt, A.S., Barvaliya, Y.K., Dave, G.S., Kothari, R.K., Biodegradable gelatin– ciprofloxacin–montmorillonite composite hydrogels for controlled drug release and wound dressing application. Colloids Surfaces B Biointerfaces 122 (2014), 175–183.
66. [66] Stathokostopoulou, C., Tarantili, P.A., Preparation, characterization and drug release studies from poly (d, l-lactic acid)/organoclay nanocomposite films. J. Macromol. Sci. Part A 51:2 (2014), 117–124 2014.
67. [67] Iannuccelli, V., Maretti, E., Montorsi, M., Rustichelli, C., Sacchetti, F., Leo, E., Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection. Int. J. Pharm. 493:1 (2015), 295–304.
68. [68] Salahuddin, N., Abdeen, R., Drug release behavior and antitumor efficiency of 5- ASA loaded Chitosan-layered silicate nanocomposites. J. Inorg. Organomet. Polym. Mater. 23:5 (2013), 1078–1088.
69. [69] Kevadiya, B.D., Chettiar, S.S., Rajkumar, S., Bajaj, H.C., Gosai, K.A., Brahmbhatt, H., Evaluation of clay/poly (L-lactide) microcomposites as anticancer drug, 6- mercaptopurine reservoir through in vitro cytotoxicity, oxidative stress markers and in vivo pharmacokinetics. Colloids Surfaces B Biointerfaces 112 (2013), 400–407.
70. [70] Jain, S., Datta, M., Oral extended release of dexamethasone: montmorillonite–PLGA nanocomposites as a delivery vehicle. Appl. Clay Sci. 104 (2015), 182–188.
71. [71] Kaygusuz, H., Uysal, M., Adımcılar, V., Erim, F.B., Natural alginate biopolymer montmorillonite clay composites for vitamin B2 delivery. J. Bioact. Compatible Polym. 30:1 (2015), 48–56.
72. [72] Lin, J.J., Lin, W.C., Li, S.D., Lin, C.Y., Hsu, S.H., Evaluation of the antibacterial activity and biocompatibility for silver nanoparticles immobilized on nano silicate platelets. ACS Appl. Mater. interfaces 5:2 (2013), 433–443.
73. [73] Anirudhan, T.S., Divya, P.L., Nima, J., Silylated montmorillonite based molecularly imprinted polymer for the selective binding and controlled release of thiamine hydrochloride. React. Funct. Polym. 73:8 (2013), 1144–1155.
74. [74] Del Hoyo, C., Vicente, M.A., Rives, V., Preparation of drug-montmorillonite UV- radiation protection compounds by gas-solid adsorption. Clay Miner. 36:4 (2001), 541–546.
75. [75] Huang, Y., Tao, Q., Hou, D., Hu, S., Tian, S., Chen, Y., Gui, R., Yang, L., Wang, Y., A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride. Int. J. Nanomedicine, 12, 2017, 1731.
76. [76] Corrales, T., Larraza, I., Catalina, F., Portolés, T., Ramírez-Santillán, C., Matesanz, M., Abrusci, C., In vitro biocompatibility and antimicrobial activity of poly (ε- caprolactone)/montmorillonitenanocomposites. Biomacromolecules 13 (2012), 4247–4256.
77. [77] Oh, Y.J., Choi, G., Choy, Y.B., Park, J.W., Park, J.H., Lee, H.J., Yoon, Y.J., Chang, H.C., Choy, J.H., Aripiprazole montmorillonite: a new organic–inorganic nanohybrid material for biomedical applications. Chemistry–A Eur. J. 19:15 (2013), 4869–4875.
78. [78] Jain, S., Datta, M., Montmorillonite-alginate microspheres as a delivery vehicle for oral extended release of Venlafaxine hydrochloride. J. Drug Deliv. Sci. Technol. 33 (2016), 149–156.
79. [79] Bounabi, L., Mokhnachi, N.B., Haddadine, N., Ouazib, F., Barille, R., Development of poly (2-hydroxyethyl methacrylate)/clay composites as drug delivery systems of paracetamol. J. Drug Deliv. Sci. Technol. 33 (2016), 58–65.
80. [80] Liyanage, A.U., Ikhuoria, E.U., Adenuga, A.A., Remcho, V.T., Lerner, M.M., Synthesis and characterization of low-generation polyamidoamine (PAMAM) dendrimer–sodium montmorillonite (Na-MMT) clay nanocomposites. Inorg. Chem. 52 (2013), 4603–4610.
81. [81] Garea, S.A., Ghebaur, E.V., Vasile, E.U., Hybrid drug release systems based on dendrimers and montmorillonite. Mater. Plast. 50 (2013), 8–11.
82. [82] Dong, Y., Feng, S.S., Poly (d, l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26 (2005), 6068–6076.
83. [83] Feng, S.S., Mei, L., Anitha, P., Gan, C.W., Zhou, W., Poly (lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials 30 (2009), 3297–3306.
84. [84] Kevadiya, B.D., Patel, T.A., Jhala, D.D., Thumbar, R.P., Brahmbhatt, H., Pandya, M.P., Rajkumar, S., Jena, P.K., Joshi, G.V., Gadhia, P.K., Tripathi, C.B., Layered inorganic nanocomposites: promising carrier for 5-fluorouracil (5-FU). Eur. J. Pharm. Biopharm. 81 (2012), 91–101.
85. [85] Adebisi, A.O., Conway, B.R., Asare-Addo, K., The influence of fillers on theophylline release from clay matrices. Am. J. Pharmacol. Sci. 3 (2015), 120–125.
86. [86] Bakre, L.G., Sarvaiya, J.I., Agrawal, Y.K., Synthesis, Characterization, and study of drug release properties of Curcumin from polycaprolactone/organomodified montmorillonite nanocomposite. J. Pharm. Innovation 11:4 (2016), 300–307.
87. [87] Liu, K.H., Liu, T.Y., Chen, S.Y., Liu, D.M., Drug release behavior of chitosan– montmorillonite nanocomposite hydrogels following electrostimulation. Actabiomaterialia 4 (2008), 1038–1045.
88. [88] Golubeva, O.Y., Pavlova, S.V., Yakovlev, A.V., Adsorption and in vitro release of vitamin B 1 by synthetic nanoclays with montmorillonite structure. Appl. Clay Sci. 112 (2015), 10–16.
89. [89] Kaur, M., Datta, M., Diclofenac sodium adsorption onto montmorillonite: adsorption equilibrium studies and drug release kinetics. Adsorpt. Sci. Technol. 32 (2014), 36–587.
90. [90] Madusanka, N., de Silva, K.N., Amaratunga, G.A., Curcumin activated carboxymethyl cellulose–montmorillonite clay nanocomposite having enhanced curcumin release in aqueous media. Carbohydr. Polym. 134 (2015), 695–699.
91. [91] Banik, N., Iman, M., Hussain, A., Ramteke, A., Boruah, R., Maji, T.K., Soy flour nanoparticles for controlled drug delivery: effect of crosslinker and montmorillonite (MMT). New J. Chem. 37 (2013), 981–990.
92. [92] Hou, D., Hu, S., Huang, Y., Gui, R., Zhang, L., Tao, Q., Zhang, C., Tian, S., Komarneni, S., Ping, Q., Preparation and in vitro study of lipid nanoparticles encapsulating drug loaded montmorillonite for ocular delivery. Appl. Clay Sci. 119 (2016), 277–283.
93. [93] Thakur, G., Singh, A., Singh, I., Formulation and evaluation of transdermal composite films of chitosan-montmorillonite for the delivery of curcumin. Int. J. Pharm. Investigation, 6, 2016, 23.
94. [94] Mahkam, M., Abbaszad Rafi, A., Mohammad, Z.L., Preparation of novel pH-sensitive nanocomposites based on ionic-liquid modified montmorillonite for colon specific drug delivery system. Polym. Compos. 37 (2016), 182–187.
95. [95] McGinity, J.W., Lack, J.L., Sustained-release applications of montmorillonite interaction with amphetamine sulfate. J. Pharm. Sci. 66 (1977), 63–66.
96. [96] Kaygusuz, H., Uysal, M., Adımcılar, V., Erim, F., Natural alginate biopolymer montmorillonite clay composites for vitamin B2 delivery. J. Bioact. Compatible Polymers:Biomedical Appl. 30 (2015), 48–56.
97. [97] Lin, J.J., Wei, J.C., Juang, T.Y., Tsai, W.C., Preparation of protein-silicate hybrids from polyamine intercalation of layered montmorillonite. Langmuir 23 (2007), 1995–1999.
98. [98] Assifaoui, A., Huault, L., Maissiat, C., Roullier-Gall, C., Jeandet, P., Hirschinger, J., Raya, J., Jaber, M., Lambert, J.F., Cayot, P., Gougeon, R.D., Structural studies of adsorbed protein (betalactoglobulin) on natural clay (montmorillonite). RSC Adv. 4 (2014), 61096–61103 2014.
99. [99] Sun, B., Ranganathan, B., Feng, S.S., Multifunctional poly (D, L-lactide-co- glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 29 (2008), 475–486.
100. [100] Hashizume, H., Adsorption of nucleic acid bases, ribose, and phosphate by some clay minerals. Life 5 (2015), 637–650.
101. [101] Sironmani, T.A., Comparison of nanocarriers for gene delivery and nanosensing using montmorillonite, silver nanoparticles and multiwalled carbon nanotubes. Appl. Clay Sci. 103 (2015), 55–61.
102. [102] Kawase, M., Hayashi, Y., Kinoshita, F., Yamato, E., Miyazaki, J.I., Yamakawa, J., Ishida, T., Tamura, M., Yagi, K., Protective effect of montmorillonite on plasmid DNA in oral gene delivery into small intestine. Biol. Pharm. Bull. 27 (2004), 2049–2051.
103. [103] Franchi, M., Ferris, J.P., Gallori, E., Cations as mediators of the adsorption of nucleic acids on clay surfaces in prebiotic environments. Orig. Life Evol. Biosphere 33 (2003), 1–6.
104. [104] Lin, F.H., Chen, C.H., Cheng, W.T., Kuo, T.F., Modified montmorillonite as vector for gene delivery. Biomaterials 27 (2006), 3333–3338.
105. [105] Lagaly, G., Reese, M., Abend, S., Smectites as colloidal stabilizers of emulsions: II. Rheological properties of smectite-laden emulsions. Appl. clay Sci. 14 (1999), 279–298.
106. [106] Guillot, S., Bergaya, F., de Azevedo, C., Warmont, F., Tranchant, J.F., Internally structured pickering emulsions stabilized by clay mineral particles. J. Colloid Interface Sci. 333 (2009), 563–569.
107. [107] Abdel-Wahhab, M.A., Nada, S.A., Khalil, F.A., Physiological and toxicological responses in rats fed aflatoxin-contaminated diet with or without sorbent materials. Anim. Feed Sci. Tech. 97 (2002), 209–219.
108. [108] Lee, Y.H., Kuo, T.F., Chen, B.Y., Feng, Y.K., Wen, Y.R., Lin, W.C., Lin, F.H., Toxicity assessment of montmorillonite as a drug carrier for pharmaceutical applications: yeast and rats model. Biomed. Eng. Appl. Basis Commun. 17 (2005), 72–78.
109. [109] Wiles, M.C., Huebner, H.J., Afriyie-Gyawu, E., Taylor, R.J., Bratton, G.R., Phillips, T.D., Toxicological evaluation and metal bioavailability in pregnant rats following exposure to clay minerals in the diet. J. Toxicol. Environ. Health, Part A. 67 (2004), 863–874.
110. [110] Afriyie-Gyawu, E., Mackie, J., Dash, B., Wiles, M., Taylor, J., Huebner, H., Tang, L., Guan, H., Wang, J.S., Phillips, T., Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley rats. Food Addit. Contam. 22 (2005), 259–269.
111. [111] Subramaniam, M.D., Kim, I.H., Clays as dietary supplements for swine: a review. J. animal Sci. Biotechnol., 6(1), 2015, 38.
112. [112] Xin, S., Li, X., Zhu, Y., Zhang, T., Lei, Z., Li, W., Zhou, X., Deng, H., Nanofibrous mats coated by homocharged biopolymer-layered silicate nanoparticles and their antitumor activity. Colloids Surfaces B Biointerfaces 105 (2013), 137–143.
113. [113] Janer, G., Fernández-Rosas, E., Mas del Molino, E., González-Gálvez, D., Vilar, G., López- Iglesias, C., Ermini, V., Vázquez-Campos, S., In vitro toxicity of functionalised nanoclays is mainly driven by the presence of organic modifiers. Nanotoxicology 8:3 (2014), 279–294.
114. [114] Maisanaba, S., Pichardo, S., Puerto, M., Gutiérrez-Praena, D., Cameán, A.M., Jos, A., Toxicological evaluation of clay minerals and derived nanocomposites: a review. Environ. Res. 138 (2015), 233–254.
115. [115] Maisanaba, S., Gutiérrez-Praena, D., Pichardo, S., Moreno, F.J., Jordá, M., Cameán, A.M., Aucejo, S., Jos, Á., Toxic effects of a modified montmorillonite clay on the human intestinal cell line Caco-2. J. Appl. Toxicol. 34:6 (2014), 714–725.
116. ® 30B. Mutat. Research/Genetic Toxicol. Environ. Mutagen. 770 (2014), 66–71.
117. [117] Mitchell, N.J., Kumi, J., Aleser, M., Elmore, S.E., Rychlik, K.A., Zychowski, K.E., Romoser, A.A., Phillips, T.D., Ankrah, N.A., Short-term safety and efficacy of calcium montmorillonite clay (UPSN) in children. Am. J. Trop. Med. Hyg. 91:4 (2014), 777–785.